E1210
E1210 is an isoxazole-based broad-spectrum antifungal.[1] E1210 targets GPI-protein biosynthesis.
![]() | |
Names | |
---|---|
Preferred IUPAC name
6-Oxa-1(3),7(2)-dipyridina-2(5,3)-[1,2]oxazola-4(1,4)-benzenaheptaphan-12-amine | |
Identifiers | |
3D model (JSmol) |
|
ChEMBL | |
ChemSpider | |
PubChem CID |
|
UNII | |
| |
| |
Properties | |
C12H18N4O2 | |
Molar mass | 250.302 g·mol−1 |
Hazards | |
GHS labelling: | |
![]() ![]() | |
Warning | |
H302, H411 | |
P264, P270, P273, P301+P312, P330, P391, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references |
References
- Pfaller, Michael A.; Hata, Katsura; Jones, Ronald N.; Messer, Shawn A.; Moet, Gary J.; Castanheira, Mariana (2011). "In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida SPP. As determined by CLSI broth microdilution method". Diagnostic Microbiology and Infectious Disease. 71 (2): 167–170. doi:10.1016/j.diagmicrobio.2011.05.001. PMID 21696907.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.